The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Rubin, David
One or more keywords matched the following items that are connected to Rubin, David
Item TypeName
Concept Biological Therapy
Concept Exercise Therapy
Concept Drug Therapy, Combination
Concept Extravasation of Diagnostic and Therapeutic Materials
Concept Treatment Refusal
Concept Salvage Therapy
Concept Treatment Outcome
Concept Therapeutic Human Experimentation
Concept Medication Therapy Management
Concept Treatment Failure
Concept Withholding Treatment
Academic Article Ethics of a paired-kidney-exchange program.
Academic Article Treatment of anal fissures with topical nitroglycerin.
Academic Article Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Academic Article The challenge of compliance and persistence: focus on ulcerative colitis.
Academic Article Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.
Academic Article Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
Academic Article Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
Academic Article Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial.
Academic Article Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
Academic Article Risk of post-operative complications associated with anti-TNF therapy in inflammatory bowel disease.
Academic Article Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.
Academic Article A practical, evidence-based guide to the use of adalimumab in Crohn's disease.
Academic Article Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution.
Academic Article We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing?
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
Academic Article Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
Academic Article Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study.
Academic Article Will a 5-ASA a day keep the cancer (and dysplasia) away?
Academic Article Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.
Academic Article Role of antibiotics in the management of inflammatory bowel disease: a review.
Academic Article Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Academic Article Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
Academic Article Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
Academic Article Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
Academic Article Patient perceptions of fecal microbiota transplantation for ulcerative colitis.
Academic Article Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
Academic Article The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
Academic Article Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Academic Article Patchy colitis and interstitial lung disease.
Academic Article Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
Academic Article Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
Academic Article Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.
Academic Article Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
Academic Article Use of Serum Infliximab Level Prior to Cyclosporine Salvage Therapy in Severe Ulcerative Colitis.
Academic Article Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash.
Academic Article Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Academic Article Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy.
Academic Article Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
Academic Article Vedolizumab in the treatment of Crohn's disease.
Academic Article Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
Academic Article When Should Therapy for Inflammatory Bowel Disease Be Stopped?
Academic Article Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis.
Academic Article Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
Academic Article Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Academic Article Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
Academic Article Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease.
Academic Article Long-term Efficacy of Vedolizumab for Ulcerative Colitis.
Academic Article Long-term Efficacy of Vedolizumab for Crohn's Disease.
Academic Article Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
Academic Article Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Academic Article The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
Academic Article Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Academic Article Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease.
Academic Article Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States.
Academic Article Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Academic Article Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
Academic Article Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
Academic Article Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis.
Academic Article Emerging Therapies for Inflammatory Bowel Disease.
Academic Article Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
Academic Article Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies.
Academic Article Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
Academic Article Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
Academic Article Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Academic Article Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
Academic Article The use of tofacitinib in the treatment of inflammatory bowel disease.
Academic Article Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.
Academic Article Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
Academic Article Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.
Academic Article Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
Academic Article Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients.
Academic Article Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
Academic Article Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
Academic Article The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
Academic Article Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
Academic Article Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.
Academic Article Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
Academic Article Patient and physician preferences for ulcerative colitis treatments in the United States.
Academic Article Treatment De-Escalation in Patients With Inflammatory Bowel Disease.
Academic Article Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
Academic Article Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis.
Academic Article Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis.
Academic Article Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Academic Article Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
Academic Article Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
Academic Article Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis.
Academic Article Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
Academic Article Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
Academic Article Emerging treatment options for extraintestinal manifestations in IBD.
Academic Article Long-term safety of vedolizumab for inflammatory bowel disease.
Academic Article Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
Academic Article Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection.
Academic Article Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
Academic Article The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
Academic Article Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes.
Academic Article Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment.
Academic Article Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis.
Academic Article STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Academic Article New targets in inflammatory bowel disease therapy: 2021.
Academic Article Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.
Academic Article Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
Academic Article Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Academic Article Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
Academic Article Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study.
Academic Article Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib.
Academic Article A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
Academic Article Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Academic Article Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
Academic Article Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center.
Academic Article Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.
Academic Article Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Academic Article Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Academic Article Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
Academic Article Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial.
Academic Article Sphingosine-1 Phosphate Receptor Modulators: The Next Wave of Oral Therapies in Inflammatory Bowel Disease.
Academic Article Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis.
Academic Article Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Academic Article Treat-to-target and sequencing therapies in Crohn's disease.
Academic Article Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open.
Academic Article Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease.
Academic Article Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States.
Academic Article Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction.
Academic Article Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy.
Academic Article Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data.
Academic Article Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience.
Concept Time-to-Treatment
Academic Article Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open
Academic Article Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
Academic Article Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
Academic Article Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry.
Academic Article Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Academic Article Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme.
Academic Article Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY.
Academic Article Real World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.
Academic Article Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn's Disease.
Academic Article Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center.
Academic Article Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Academic Article Impact of a health-system specialty pharmacy on time to upadacitinib initiation.
Academic Article Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study.
Academic Article Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY.
Academic Article Successful Treatment of Severe Pyoderma Gangrenosum and Ulcerative Colitis With Upadacitinib.
Academic Article Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program.
Academic Article Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
Academic Article Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays.
Academic Article Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12.
Academic Article Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD study.
Academic Article Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn's Disease.
Academic Article Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis.
Academic Article Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-diabetic Patients with Inflammatory Bowel Disease.
Academic Article Challenging Conventional Care: Ethical Considerations of De-intensification of Therapy in IBD.
Academic Article Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Academic Article Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.
Academic Article Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies.
Academic Article Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial.
Academic Article Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial.
Academic Article A practical approach to positioning therapies in ulcerative colitis.
Academic Article Rare Complication of Endoscopic Variceal Therapy: Wide-Complex Tachycardia Associated With Embolization of Glue and Coil.
Academic Article Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.
Academic Article Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease.
Academic Article P042 Early Versus Later Use of Vedolizumab In IBD: Patient Characteristics And Treatment Patterns In The Real World (RALEE).
Academic Article Mirikizumab in the Treatment of Ulcerative Colitis: Initial Real-World Data in a Population from a Large Tertiary Center.
Academic Article Exercise Therapies for Fibromyalgia Pain Catastrophizing: A Systematic Review and Comparative Analysis.
Academic Article Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT Trials.
Academic Article Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis.
Academic Article Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.
Academic Article Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis.
Academic Article An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.
Academic Article Real-world Experience of Upadacitinib Reinduction and High-dose Maintenance Therapy in Inflammatory Bowel Disease.
Academic Article Comparative Effectiveness of Tofacitinib vs Upadacitinib for the Treatment of Acute Severe Ulcerative Colitis.
Academic Article New Eczematous Eruption in Patients With Inflammatory Bowel Disease Who Stop Janus Kinase Inhibitors.
Academic Article Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials.
Academic Article Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.
Search Criteria
  • Therapeutics